The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACURA PHARMACEUTICALS INC | COM | 00509L802 | 372 | 1,956,397 | SH | SOLE | 1,956,397 | 0 | 0 | ||
| AXOGEN INC | COM | 05463X106 | 136,754 | 3,711,111 | SH | SOLE | 3,711,111 | 0 | 0 | ||
| CATALYST | COM | 14888D109 | 861 | 78,622 | SH | SOLE | 78,622 | 0 | 0 | ||
| CORIUM | COM | 21887L107 | 88,950 | 9,353,304 | SH | SOLE | 9,353,304 | 0 | 0 | ||
| ENDOLOGIX INC | COM | 29266S106 | 6,684 | 1,257,468 | SH | SOLE | 1,257,468 | 0 | 0 | ||
| EYEPOINT | COM | 74440J101 | 149,597 | 41,903,956 | SH | SOLE | 41,903,956 | 0 | 0 | ||
| MEDICINOVA INC | COM | 58468P206 | 14,618 | 1,170,370 | SH | SOLE | 1,170,370 | 0 | 0 | ||
| REVANCE THERAPEUTICS INC | COM | 761330109 | 83,050 | 3,342,047 | SH | SOLE | 3,342,047 | 0 | 0 | ||